Natco Pharma sees major leadership exit in RnD, demand & supply, quality
Hyderabad: Natco Pharma has announced that Dr Muddasaani Pulla Reddy, Executive Vice President - R & D and CH Srinivas, Senior Vice President - Demand & Supply have superannuated from the Company.
Earlier in April, Natco Pharma also announced the superannuation of two key executives: Dr. Ramesh Dandala, Executive Vice President – Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), and Tummala Venkata Rao, Vice President – Production.
NATCO Pharma Limited, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharma ingredients and crop protection products. Natco is a R&D oriented, and a science driven, Oncology company in the targeted therapies of domestic market and focuses on limited competition molecule in the US. The Company’s manufacturing facilities are approved by several leading regulatory authorities like US FDA, Brazil ANVISA, Health Canada, WHO and others catering to 50+ global markets.
Read also: Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President - Operations at Mekaguda
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.